Procurement Request
Home>Supplier>ShangHai Twochem Co.,Ltd>Idelalisib

ShangHai Twochem Co.,Ltd

ShangHai Twochem Co.,Ltd

Certified Store
Custom-Made
China Shanghai Fengxian
sales@twochem.com
15800915896
021-58111628

Catalog No. : T0033

Idelalisib

  • 870281-82-6
  • 1kg
  • 99%
  • 14Day (s)
Packing :
More

Request For Quotation

  • Product Details & Description

Product Info

Compound Idelalisib
CAS No. 870281-82-6 Catalog No. T0033 Brand
Purity 99% Packing 1kg Grade
Lead Time 14Day (s) Origin Loading Port

Description

Idelalisib (CAL-101, GS-1101) is a selective p110 inhibitor with IC50 of 2.5 nM in cell-free assays; shown to have 40- to 300-fold greater selectivity for p110 than p110//, and 400- to 4000-fold more selectivity to p110 than C2, hVPS34, DNA-PK and mTOR.

CAL-101 is not sensitive to other PI3K class I subunits including p110, p110, and p110. CAL-101 specifically blocks FcR1 p110-mediated CD63 expression with an EC50 of 8 nM in primary basophil. CAL-101 exhibits greater activity in B-cell acute lymphoblastic leukemia (B-ALL) and chronic lymphocytic leukemia (CLL) cells compared with acute myeloid leukemia (AML) and myeloproliferative neoplasm (MPN) cells. CAL-101 produces the reduction in pAktS473, pAktT308, and the downstream target S6 in SU-DHL-5, KARPAS-422 and CCRF-SB cells with EC50 of 0.1 to 1.0 M. CAL-101 induces selective cytotoxicity in CLL cells independent of IgVH mutational status or interphase cytogenetics, primarily through a caspase-dependent mechanism. CAL-101 induces cytotoxicity preferentially to CLL cells compared with normal B cells, without producing cytotoxicity in other hematopoietic cells, compared to LY294002. CAL-101 lacks direct cytotoxic potential to T cells and nature killer (NK) cells. CAL-101 can inhibit production of inflammatory cytokines, such as IL-6, IL-10, TNF-, and IFN-, and activation-induced cytokines, such as CD40L. CAL-101 also antagonizes CD40L-mediated CLL cell survival.CAL-101 induces an accumulation of cells in G1 and a decrease in the S-phase population in L1236 and L591 cells, which indicates CAL-101 as a novel strategy for the treatment of hodgkin lymphoma (HL). 

Request For Quotation

Product

Idelalisib

Cas No

870281-82-6

*Purity
*Quantity
*Valid for
*Shipping To
Contact Person
*Email
*Company/Institute
Notes

I would like to have suppliers recommended by MOLBASE.

I agree to share my contact information to the supplier(s).

Other Supplier Reference

Product Name Purity Packing Lead Time Country Store Name Details
Idelalisib 99% 1g 3Day (s) China,Shaanxi
Baoji Guokang Bio-Technology Co., Ltd
Request For Quotation
4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]- 98% 10g 3Day (s) China,Zhejiang
Wenzhou Win-Win Chemical Co., Ltd.
Request For Quotation
Idelalisib ≥97% 1kg 14Day (s) China,Zhejiang
Hangzhou J&H Chemical Co., Ltd.
Request For Quotation
Idelalisib 98% 1kg 7Day (s) China,Zhejiang
Hangzhou J&H Chemical Co., Ltd.
Request For Quotation
5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-4(3H)-quinazolinone 99.00% 1kg,10g 3Day (s) China,Zhejiang
Hangzhou Pharma & Chem Co., Ltd.
Request For Quotation
CAL-101 99% 1kg 7Day (s) China,Zhejiang
Skyrun Industrial Co., Limited
Request For Quotation
CAL-101 98% 1kg 2-3Day (s) China,Henan
Henan Coreychem Co.,Ltd
Request For Quotation
CAL-101 98% 5g 5Day (s) China,Jiangsu
Jiangsu Bida Pharmaceutical Technology Co., Ltd.
Request For Quotation
Idelalisib 99% 50mg,10mg 1Week (s) China,Shanghai Shanghai Jizhi Biochemical Technology Co., Ltd. Request For Quotation
Idelalisib 99% 25kg 7Day (s) China,Zhejiang
Hangzhou DayangChem Co., Ltd
Request For Quotation
View All Suppliers